185 related articles for article (PubMed ID: 6251761)
1. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
Fagard R; Amery A; Lijnen P; Staessen J
Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761
[TBL] [Abstract][Full Text] [Related]
2. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
Stanek B; Silberbauer K
Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
[TBL] [Abstract][Full Text] [Related]
3. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
[TBL] [Abstract][Full Text] [Related]
4. [Effect of captopril in essential hypertension (author's transl)].
Mimran A; Targhetta R; Laroche B
Nouv Presse Med; 1981 Apr; 10(19):1579-82. PubMed ID: 7025849
[TBL] [Abstract][Full Text] [Related]
5. Treatment of moderate to severe hypertensive patients with an orally active converting-enzyme inhibitor.
Prins EJ; Donker AJ; Hoorntje SJ; Leenen FH; van der Hem GK
Proc Eur Dial Transplant Assoc; 1979; 16():603-9. PubMed ID: 232914
[TBL] [Abstract][Full Text] [Related]
6. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
7. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
[TBL] [Abstract][Full Text] [Related]
9. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
Overlack A; Stumpe KO; Heck I; Krück F
Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
11. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with the angiotensin converting enzyme inhibitor captopril.
Walter NM; Whitworth JA; Kincaid-Smith P
Clin Exp Pharmacol Physiol Suppl; 1982; 7():117-21. PubMed ID: 6291829
[TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
[No Abstract] [Full Text] [Related]
14. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
[TBL] [Abstract][Full Text] [Related]
15. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
16. [Captopril in the treatment of essential hypertension (author's transl)].
Lederle RM; Klaus D; Braun B
Dtsch Med Wochenschr; 1980 Sep; 105(38):1307-12. PubMed ID: 6257467
[TBL] [Abstract][Full Text] [Related]
17. Relationship between vasopressin and the renin-angiotensin-aldosterone system in essential hypertension: effect of converting enzyme inhibitor on plasma vasopressin.
Santucci A; Leonetti Luparini R; Ferri C; Ficara C; Giarrizzo C; Balsano F
J Hypertens Suppl; 1985 Nov; 3(2):S133-4. PubMed ID: 3003302
[TBL] [Abstract][Full Text] [Related]
18. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
[No Abstract] [Full Text] [Related]
19. Effects of captopril on the development of tolerance to guanethidine.
Rankin GO; Haas GJ
Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
[TBL] [Abstract][Full Text] [Related]
20. [Effect of an oral angiotensin I-converting enzyme inhibitor on blood pressure and renin-angiotensin-aldosterone system before and after nephrectomy in two cases with acute renovascular hypertension].
Irabu N; Nakamura K; Morohashi Y; Murakami S; Kawamura K
Nihon Jinzo Gakkai Shi; 1982 Sep; 24(9):1029-39. PubMed ID: 6298493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
